Breast Cancer Survivorship: Why, What and When?

Jennifer Gass, Beth Dupree, Sandhya Pruthi, Diane Radford, Irene Wapnir, Reza Antoszewska, Audrey Curtis, Nathalie Johnson

Research output: Contribution to journalArticle

9 Scopus citations

Abstract

Survivorship medicine is fairly new in the realm of oncology. As we broaden our focus from treatment and prevention to include survivorship there is substantial opportunity to enhance the care of the patient. Important in successful management of recovery after cancer treatment is managing the side effects of therapy and improving quality of life. This ranges from sexual dysfunction, depression to lymphedema. Guideline-based surveillance after treatment with clear communication of care plans to the patient and their providers, especially primary care, is paramount. Thoughtful pre-surgical treatment planning, which may include neoadjuvant approaches or consideration of fertility preservation, results in superior long-term patient outcomes. Understanding the importance of the teachable moment in effecting behavioral and lifestyle changes that reduce risk of recurrence is also an essential component of excellent cancer survivor patient care. We identified the following areas for focus as they represent the key areas for accreditation and patient driven needs. Development of survivorship plans, post treatment surveillance, sexuality and fertility preservation, lymphedema management and risk reduction lifestyle and behavioral changes.

Original languageEnglish (US)
Pages (from-to)3162-3167
Number of pages6
JournalAnnals of Surgical Oncology
Volume23
Issue number10
DOIs
StatePublished - Oct 1 2016

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Breast Cancer Survivorship: Why, What and When?'. Together they form a unique fingerprint.

  • Cite this

    Gass, J., Dupree, B., Pruthi, S., Radford, D., Wapnir, I., Antoszewska, R., Curtis, A., & Johnson, N. (2016). Breast Cancer Survivorship: Why, What and When? Annals of Surgical Oncology, 23(10), 3162-3167. https://doi.org/10.1245/s10434-016-5403-0